Evidence map›Paper›PMID 39329067›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Consensus recommendations for clinical assessment tools for the diagnosis of posterior cortical atrophy syndrome from the Atypical AD PIA of ISTAART.

Victoria S Pelak, David F Tang-Wai, Bradley F Boeve, Femke H Bouwman, Jonathan Graff-Radford, Gil Rabinovici, Samantha K Holden, Ryan A Townley, Gregory S Day, Jennifer Whitwell and 7 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Victoria S PelakDepartments of Neurology and Ophthalmology University of Colorado School of Medicine, Aurora Victoria Colorado USA.ORCID https://orcid.org/0000-0003-3147-8595
David F Tang-WaiDepartment of Medicine (Neurology) University of Toronto Toronto Canada.
Bradley F BoeveDepartment of Neurology Mayo Clinic Rochester Minnesota USA.
Femke H BouwmanDepartment of Neurology Vrije Universiteit Amsterdam Amsterdam The Netherlands.
Jonathan Graff-RadfordDepartment of Neurology Mayo Clinic Rochester Minnesota USA.
Gil RabinoviciDepartment of Neurology University of California San Francisco San Francisco California USA.
Samantha K HoldenDepartment of Neurology University of Colorado School of Medicine Aurora Colorado USA.
Ryan A TownleyDepartment of Neurology University of Kansas School of Medicine Kansas City Kansas USA.
Gregory S DayDepartment of Neurology Mayo Clinic Jacksonville Jacksonville Florida USA.
Jennifer WhitwellDepartment of Radiology Division of Neuroradiology Mayo Clinic Rochester Minnesota USA.
Rik OssenkoppeleDepartment of Neurology Vrije Universiteit Amsterdam Amsterdam The Netherlands.
Baayla D C BoonDepartment of Neuroscience Mayo Clinic Jacksonville Jacksonville Florida USA.
Deepti PutchaDepartment of Psychiatry Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA.
Chiadi U OnyikeDepartment of Psychiatry Johns Hopkins Medicine Baltimore Maryland USA.
Heather SnyderMedical & Scientific Relations Alzheimer's Association Chicago Illinois USA.
Sebastian CrutchUCL Queen Square Institute of Neurology Dementia Research Centre London UK.
Keir X X YongUCL Queen Square Institute of Neurology Dementia Research Centre London UK.ORCID https://orcid.org/0000-0002-9708-3599

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDelay in diagnosis of posterior cortical atrophy (PCA) syndrome is common, and the lack of familiarity with assessment tools for identifying visual cortical dysfunction is a contributing factor. We propose recommendations for the approach to the evaluation of PCA clinical features during the office visit, the neuropsychological evaluation, and the research setting. A recommended screening battery for eye clinics is also proposed.

methodsRecommendations were developed using results from a web-based survey of members of Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART) Atypical Alzheimer's Disease Professional Interest Area (PIA), literature review, and consensus by the PCA assessment working party of the Atypical Alzheimer's Disease PIA.

resultsSurvey results revealed robust agreement for assessment tool preferences for PCA features, and many respondents indicated that they reserve assessment tools for use only when PCA is suspected. For some PCA features, curated tools were preferred over validated battery tools, particularly for the office visit. Consensus recommendations superseded survey preferences for two core cognitive features within the 2017 PCA diagnostic criteria. DISCUSSION: These consensus recommendations provide an evaluation framework for PCA clinical features and can facilitate timely and accurate recognition and diagnosis of PCA. Broader use of these tools should be sought, and development and validation of novel PCA clinical outcome assessments are needed to improve our understanding of atypical AD and other dementias and support the inclusion of those with PCA in treatment trials.

Indexed as

Alzheimer's diseaseassessment toolsAtypical Alzheimer's Disease Professional Interest Areaclinical outcome assessmentsPCA clinical featuresposterior cortical atrophy

Identifiers

PMID39329067
PMCPMC11425198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.